51991-959 : Miglustat 100 mg Oral Capsule
NDC: | 51991-959 |
Labeler: | Breckenridge Pharmaceutical, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Miglustat |
Dosage Form: | Oral Capsule |
Application #: | ANDA209325 |
Rev. Date: |
NDC Package Codes:
- 51991-959-90: 90 CAPSULE IN 1 BOTTLE (51991‑959‑90)
Active Ingredients:
- Miglustat
Dosage Strength:
- 100 mg
Pharmaceutical Classes:
- Glucosylceramide Synthase Inhibitor [EPC]
- Glucosylceramide Synthase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 10148-201 Miglustat 100 mg Oral Capsule by Cotherix, Inc.
- 42799-708 Miglustat 100 mg Oral Capsule by Edenbridge Pharmaceuticals LLC.
- 43975-310 Miglustat 100 mg Oral Capsule by Amerigen Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 51991-958Next: 51991-961 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.